An assessment of nucleic acid amplification testing for active mycobacterial infection



Yüklə 3,88 Mb.
səhifə38/143
tarix04.01.2022
ölçüsü3,88 Mb.
#60347
1   ...   34   35   36   37   38   39   40   41   ...   143
Element of clinical question

Search terms

Population

(tuberculosis OR MTB OR MTB/RIF OR “tubercle bacillus” OR Tuberculosis [MeSH] OR Mycobacterium OR “M. africanum” OR “M. bovis” OR “M. microti” OR “M. canettii” OR “M. caprae” OR “M. pinnipedii” OR “M. mungi”) AND (“rpoB protein, Mycobacterium tuberculosis” [Supplementary Concept] OR rpoB OR resistant OR resistance OR “multidrug resistant” OR MDR OR “Drug resistance, Bacterial” [MeSH])

Intervention

N/A

Comparator (if applicable)

(Rifampin [MeSH] OR rifampicin OR benemycin OR rimactan OR tubacin OR rifadin OR rimactane OR isoniazid)

Outcomes (if applicable)

(infectious OR contagious OR contacts OR delay OR “excess morbidity” OR “excess mortality” OR public health OR outbreak)

Limits

1990 – June 2014; NOT (Other Animals NOT Humans)

MeSH = Medical Subject Heading, based on a Medline/PubMed platform; N/A = not applicable

Table Search terms used for impact of early versus delayed treatment for TB




Yüklə 3,88 Mb.

Dostları ilə paylaş:
1   ...   34   35   36   37   38   39   40   41   ...   143




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©muhaz.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin